期刊
CURRENT OPINION IN PHARMACOLOGY
卷 48, 期 -, 页码 48-56出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2019.04.016
关键词
-
资金
- PAPIIT-UNAM [IN209617, IA202116]
- CONACYT [CB 255287, 284081]
As current levels of antimicrobial resistance are alarming, the World Health Organization urged the development of new antimicrobials to fight infections produced by multidrug resistant bacteria. Antibiotics impose severe selective pressure for the development of resistance, and currently bacteria resistant to all of them exist. In this review, we discuss the release and development of new antibacterial drugs and their properties as well as the current advances in the development of alternative approaches to combat bacterial infections, including the repurposing of drugs, anti-virulence therapies, the use of photosensitizers, phage therapy, and immunotherapies, with an emphasis on what is currently known about the possible development of bacterial resistance against them.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据